Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001279569-16-002896
Filing Date
2016-03-09
Accepted
2016-03-09 16:39:59
Documents
17
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v433521_10k.htm 10-K 1467996
2 EXHIBIT 16.1 v433521_ex16-1.htm EX-16.1 3146
3 EXHIBIT 21.1 v433521_ex21-1.htm EX-21.1 1196
4 EXHIBIT 23.1 v433521_ex23-1.htm EX-23.1 2883
5 EXHIBIT 23.2 v433521_ex23-2.htm EX-23.2 3081
6 EXHIBIT 31.1 v433521_ex31-1.htm EX-31.1 7603
7 EXHIBIT 31.2 v433521_ex31-2.htm EX-31.2 7426
8 EXHIBIT 32.1 v433521_ex32-1.htm EX-32.1 5461
9 GRAPHIC tpg13a.jpg GRAPHIC 38051
10 GRAPHIC tpg13b.jpg GRAPHIC 45026
11 GRAPHIC tpg17.jpg GRAPHIC 70208
12 GRAPHIC tpg19.jpg GRAPHIC 49124
13 GRAPHIC tpg20.jpg GRAPHIC 30659
14 GRAPHIC tpg22.jpg GRAPHIC 35606
15 GRAPHIC tpg23.jpg GRAPHIC 38346
16 GRAPHIC tpg24.jpg GRAPHIC 61207
17 GRAPHIC comparison5yearchart.jpg GRAPHIC 46601
  Complete submission text file 0001279569-16-002896.txt   2072196
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

EIN.: 981226819 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37426 | Film No.: 161495019
SIC: 2834 Pharmaceutical Preparations